Literature DB >> 8318680

Angiotensin II receptor subtypes in the kidney.

R M Edwards, N Aiyar.   

Abstract

The kidney is an important target organ for angiotensin II. The diverse biologic effects of angiotensin II in the kidney and periphery suggest that angiotensin II may be interacting with more than one receptor. Recently, the synthesis of highly selective nonpeptide angiotensin II receptor antagonists and the expression cloning of the angiotensin receptor have unequivocally demonstrated the existence of at least two angiotensin II receptor subtypes, designated AT1 and AT2. Autoradiography and ligand binding studies have shown that most tissues, including the kidney, have a mixture of both receptor subtypes. The AT1 receptor is coupled via G proteins to traditional signal transduction mechanisms such as stimulation of phospholipase C, Ca2+ mobilization, and inhibition of adenylate cyclase. The AT2 receptor does not appear to be coupled to G proteins, and the signal transduction pathway(s) associated with this receptor is not known but may involve cGMP. In the kidney, as in the periphery, all of the major physiologic actions of angiotensin II appear to be mediated by activation of the AT1 receptor. In this review, the general characteristics of the AT1 and AT2 receptors and their distribution and function in the kidney will be discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318680     DOI: 10.1681/ASN.V3101643

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  11 in total

1.  Angiotensin II stimulates expression of the chemokine RANTES in rat glomerular endothelial cells. Role of the angiotensin type 2 receptor.

Authors:  G Wolf; F N Ziyadeh; F Thaiss; J Tomaszewski; R J Caron; U Wenzel; G Zahner; U Helmchen; R A Stahl
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Regulation of angiotensin II receptor AT1 subtypes in renal afferent arterioles during chronic changes in sodium diet.

Authors:  X Ruan; C Wagner; C Chatziantoniou; A Kurtz; W J Arendshorst
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

Review 3.  Eprosartan: a review of its use in the management of hypertension.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

Review 4.  Eprosartan: a review of its use in the management of hypertension.

Authors:  Gayle W Robins; Lesley J Scott
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Type-1 angiotensin receptors are expressed and transported in motor and sensory axons of rat sciatic nerves.

Authors:  Hui Tang; Jaroslav Pavel; Juan M Saavedra; Stephen Brimijoin
Journal:  Neuropeptides       Date:  2009-02-23       Impact factor: 3.286

6.  Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophic and hyperplastic agonists.

Authors:  A Huwiler; S Stabel; D Fabbro; J Pfeilschifter
Journal:  Biochem J       Date:  1995-02-01       Impact factor: 3.857

Review 7.  Renal pericytes: regulators of medullary blood flow.

Authors:  T M Kennedy-Lydon; C Crawford; S S P Wildman; C M Peppiatt-Wildman
Journal:  Acta Physiol (Oxf)       Date:  2012-11-06       Impact factor: 6.311

8.  TNF/Ang-II synergy is obligate for fibroinflammatory pathology, but not for changes in cardiorenal function.

Authors:  Magdalena Mayr; Clemens Duerrschmid; Guillermo Medrano; George E Taffet; Yanlin Wang; Mark L Entman; Sandra B Haudek
Journal:  Physiol Rep       Date:  2016-04-27

Review 9.  Involvement of myosin regulatory light chain diphosphorylation in sustained vasoconstriction under pathophysiological conditions.

Authors:  Kosuke Takeya; Xuemei Wang; Cindy Sutherland; Iris Kathol; Kathy Loutzenhiser; Rodger D Loutzenhiser; Michael P Walsh
Journal:  J Smooth Muscle Res       Date:  2014

Review 10.  Highly sensitive myosin phosphorylation analysis in the renal afferent arteriole.

Authors:  Kosuke Takeya
Journal:  J Smooth Muscle Res       Date:  2016
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.